Seeing Is Believing
with an average price target of $22.84. This is a potential upside of $21.78 (2054.72%) from yesterday's end of day stock price of $1.06.
Enlivex Therapeutics Ltd's activity chart (see below) currently has 11 price targets and 9 ratings on display.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 187.67 days.
Highest price target for ENLV is $13, Lowest price target is $13, average price target is $13.
Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 26-Sep-2025. First documented stock forecast 17-Feb-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$13
$11.97 (1162.14%)
$13
9 days ago
(26-Sep-2025)
0/9 (0%)
$11.97 (1162.14%)
Buy
$6
$4.94 (466.04%)
1 years 3 months 24 days ago
(11-Jun-2024)
2/4 (50%)
$4.58 (322.54%)
366
Buy
$120
$118.94 (11220.75%)
$184
9 years 1 months 10 days ago
(25-Aug-2016)
2/4 (50%)
$48.8 (68.54%)
197
What is ENLV (Enlivex Therapeutics Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on ENLV (Enlivex Therapeutics Ltd) with a proven track record?
Which analyst has the current lower performing score on ENLV (Enlivex Therapeutics Ltd) with a proven track record?
Which analyst has the most public recommendations on ENLV (Enlivex Therapeutics Ltd)?
Which analyst is the currently most bullish on ENLV (Enlivex Therapeutics Ltd)?
Which analyst is the currently most reserved on ENLV (Enlivex Therapeutics Ltd)?